Skip to content
Log in
Sponsored AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI

MICAL2 as a key effector of β-catenin signaling driving melanoma progression and therapeutic resistance.

P. Sohier J. Raymond Zackie Aktary N. Zidi Lara Araktingi N. Charoenchon Céline Pisibon Sylvie Caberia É. Pasmant Nicolas Macagno V. Delmas C. Gaudy-Marqueste E. Steingrímsson R. Ballotti Valérie Petit L. Larue
Aug 2026 · Cell Death and Differentiation · 0 citations · 56 references
Medicine

TL;DR

It is demonstrated that activation of β-catenin is associated with a poor prognosis in melanoma and inhibiting the enzymatic activity of MICAL2 offers a promising and innovative strategy to improve outcomes in β-catenin-driven melanoma.

DOI PubMed Semantic Scholar
View source

Similar papers

#protein folding Aug 2026

PRDX1 drives colorectal cancer progression and immune microenvironment remodeling by facilitating PRMT5 nuclear translocation to activate Wnt/β-catenin signaling.

Findings identify a novel PRDX1-PRMT5 axis that activates Wnt/β-catenin signaling, highlighting a potential therapeutic strategy for CRC by targeting this pathway to suppress tumor progression and remodel the immune microenvironment.

Nianhua Yu, Xi Li, Jin-Li Han et al. · 0 citations
Review Open access Jul 2026

Therapeutic targeting of β-catenin in cancer.

Effective targeting of β-catenin has the potential to address extensive unmet patient needs in hard-to-treat cancer types such as colorectal cancer, hepatocellular carcinoma as well as other cancers driven by WNT/β-catenin pathway alterations.

Paola Martinelli, Peter Repiscak, N. Kraut · 0 citations
Review Jul 2026

The multifaceted role of SOCS3 in colorectal cancer: molecular mechanisms and clinical implications

Clinically, reduced SOCS3 expression has been associated with lymph node metastasis, advanced TNM stage, and poorer prognosis, whereas higher SOCS3 levels may correlate with improved outcomes and chemosensitivity, and further translational studies are needed to validate SOCS3 as a biomarker and therapeutic target in CR...

Hesan Abbasi, S. Razi, Nima Rezaei · 0 citations
Open access Aug 2026

CAF-derived TGF-β1 activates an LBH-mediated β-catenin stabilization program to drive gastric cancer progression

It is shown that the transcriptional cofactor LBH drives mutation-independent Wnt activation and malignant progression in GC via a tumour microenvironment-regulated post-translational stabilization mechanism, elucidate a critical tumour–stroma crosstalk mechanism and establish the targeted disruption of the LBH–β-caten...

Zhi-Xiong Su, Guifeng Zhang, J. Zhong et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.